Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Dysferlin mutations cause muscular dystrophy, leading to impaired membrane repair and muscle weakness.
• Growth-promoting strategies like insulin-like growth factor 1 (IGF-1) may benefit patients but can cause side effects.
• Investigating IGF-1's efficacy in the context of dysferlin deficiency is crucial for therapeutic development.

Purpose of the Study:

• To determine if locally increased IGF-1 can promote functional muscle hypertrophy in dysferlin-null mice.

Main Methods:

• Utilized muscle-specific transgenic expression and viral delivery of Igf1 in dysferlin-null and control mice.
• Quantified increased IGF-1 levels using enzyme-linked immunosorbent assay.
• Assessed skeletal muscle mass and function in both male and female mice.

Main Results:

• Muscle hypertrophy was observed in response to increased IGF-1 in both dysferlin-deficient and control mice.
• Male mice exhibited a more pronounced hypertrophic response compared to female mice.
• Elevated IGF-1 levels did not impair specific force production in dysferlin-null muscles.

Conclusions:

• Increased local IGF-1 effectively promotes functional muscle hypertrophy even in the absence of dysferlin.
• IGF-1 reemerges as a promising therapeutic candidate for treating dysferlinopathies.